Literature DB >> 7588956

Histiocytoses.

J L Stéphan1.   

Abstract

Childhood histiocytoses are a rare and diverse group of histiocytic disorders. This review will focus on clinical, pathological and immunopathological features of these syndromes. The pathogenesis of Langerhans' cell histiocytosis or class I histiocytosis, a proliferative disorder of the Langerhans' cell, remains enigmatic. Approaches to treatment are as varied as the clinical presentations, ranging from a fatal leukaemia-like disorder to solitary lytic lesions of bone. Recent findings indicate that Langerhans' cell histiocytosis is a clonal histiocytic disease. The two major class II histiocytoses are familial erythrophagocytic lymphohistiocytosis and the reactive haemophagocytic syndromes. The clinicopathological similarities between these two entities suggest that they share a common immunological feature in which uncontrolled cytokine release from activated T-cells leads macrophages to a haemophagocytosing state.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7588956     DOI: 10.1007/BF02079059

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  79 in total

1.  Familial haemophagocytic reticulosis.

Authors:  J W FARQUHAR; A E CLAIREAUX
Journal:  Arch Dis Child       Date:  1952-12       Impact factor: 3.791

Review 2.  Congenital self-healing reticulohistiocytosis. Report of a case with 7-year follow-up and a review of the literature.

Authors:  J B Alexis; R J Poppiti; E Turbat-Herrera; M D Smith
Journal:  Am J Dermatopathol       Date:  1991-04       Impact factor: 1.533

3.  Papular acrodermatitis of childhood. An Australia antigen disease.

Authors:  F Gianotti
Journal:  Arch Dis Child       Date:  1973-10       Impact factor: 3.791

4.  Sinus histiocytosis with massive lymphadenopathy: a pseudolymphomatous benign disorder. Analysis of 34 cases.

Authors:  J Rosai; R F Dorfman
Journal:  Cancer       Date:  1972-11       Impact factor: 6.860

5.  Langerhans cell granulein Letterer-Siwe disease. An electron microscopic study.

Authors:  M Shamoto
Journal:  Cancer       Date:  1970-11       Impact factor: 6.860

6.  Results of treatment of 127 patients with systemic histiocytosis.

Authors:  J S Greenberger; A C Crocker; G Vawter; N Jaffe; J R Cassady
Journal:  Medicine (Baltimore)       Date:  1981-09       Impact factor: 1.889

7.  Central nervous system disease associated with Langerhans' cell histiocytosis.

Authors:  N Grois; A J Barkovich; W Rosenau; A R Ablin
Journal:  Am J Pediatr Hematol Oncol       Date:  1993-05

8.  Inflammatory cytokines in virus-associated hemophagocytic syndrome. Interferon-gamma as a sensitive indicator of disease activity.

Authors:  S Ohga; A Matsuzaki; M Nishizaki; T Nagashima; T Kai; M Suda; K Ueda
Journal:  Am J Pediatr Hematol Oncol       Date:  1993-08

9.  Langerhans'-cell histiocytosis (histiocytosis X)--a clonal proliferative disease.

Authors:  C L Willman; L Busque; B B Griffith; B E Favara; K L McClain; M H Duncan; D G Gilliland
Journal:  N Engl J Med       Date:  1994-07-21       Impact factor: 91.245

10.  Cyclosporine therapy for advanced Langerhans cell histiocytosis.

Authors:  H H Mahmoud; W C Wang; S B Murphy
Journal:  Blood       Date:  1991-02-15       Impact factor: 22.113

View more
  3 in total

1.  Langerhans cell histiocytosis with an anterior mediastinal mass involving calcification: confirmation by needle biopsy.

Authors:  K Kawasaki; T Kuga; T Matsuoka; M Takahashi; S Furukawa
Journal:  Eur J Pediatr       Date:  1997-01       Impact factor: 3.183

2.  Visceral leishmaniasis and haemophagocytic syndrome in an Omani child.

Authors:  Khalfan Al Sineidi; Yasser A Wali; Anil V Pathare; Zakia Al Lamki
Journal:  J Sci Res Med Sci       Date:  2002-04

3.  Cerebrospinal fluid involvement in a case of visceral leishmaniasis associated with hemophagocytic lymphohistiocytosis.

Authors:  Mahmoud Fathalla; Javad Hashim; Hussein Alkindy; Yasser Wali
Journal:  Sultan Qaboos Univ Med J       Date:  2007-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.